Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials.
作者信息
Lombardi Marco, Carbone Salvatore, Del Buono Marco Giuseppe, Chiabrando Juan Guido, Vescovo Giovanni Maria, Camilli Massimiliano, Montone Rocco Antonio, Vergallo Rocco, Abbate Antonio, Biondi-Zoccai Giuseppe, Dixon Dave L, Crea Filippo
机构信息
Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy.
Department of Kinesiology & Health Sciences, College of Humanities & Sciences, Virginia Commonwealth University, 500 Academic Centre, Room 113C, 1020 W Grace Street, Richmond, VA 23220, USA.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e69-e70. doi: 10.1093/ehjcvp/pvab008.
Abstract
摘要
相似文献
1
Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials.补充ω-3脂肪酸与心房颤动风险：随机对照试验的最新荟萃分析
Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e69-e70. doi: 10.1093/ehjcvp/pvab008.
2
Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.长期补充海洋 ω-3 脂肪酸对心血管结局随机对照试验中心律失常风险的影响：系统评价和荟萃分析。
Circulation. 2021 Dec 21;144(25):1981-1990. doi: 10.1161/CIRCULATIONAHA.121.055654. Epub 2021 Oct 6.
3
The coincidence of increased risk of atrial fibrillation in randomized control trials of omega-3 fatty acids: a meta-analysis.ω-3脂肪酸随机对照试验中心房颤动风险增加的一致性：一项荟萃分析。
Expert Rev Clin Pharmacol. 2021 Jun;14(6):773-775. doi: 10.1080/17512433.2021.1913051. Epub 2021 Apr 13.
4
Omega-3 polyunsaturated fatty acids in cardiac surgery patients: An updated systematic review and meta-analysis.心脏手术患者的ω-3 多不饱和脂肪酸：一项更新的系统评价和荟萃分析。
Clin Nutr. 2017 Jun;36(3):737-746. doi: 10.1016/j.clnu.2016.05.013. Epub 2016 May 27.
5
Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?鱼油补充剂可能会增加患心房颤动的风险：这意味着什么？
Circulation. 2021 Dec 21;144(25):1991-1994. doi: 10.1161/CIRCULATIONAHA.121.057464. Epub 2021 Dec 20.
6
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis.ω-3 脂肪酸治疗与心血管结局试验中心房颤动的关系：系统评价和荟萃分析。
Cardiovasc Drugs Ther. 2021 Aug;35(4):793-800. doi: 10.1007/s10557-021-07204-z. Epub 2021 May 31.
7
Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.术前补充 n-3 多不饱和脂肪酸预防心脏直视手术患者术后心房颤动：更新的荟萃分析。
J Thorac Cardiovasc Surg. 2013 Oct;146(4):906-11. doi: 10.1016/j.jtcvs.2013.03.015. Epub 2013 Apr 12.
8
Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials.用 ω-3 脂肪酸预防心房颤动：随机临床试验的荟萃分析。
Heart. 2011 Jul;97(13):1034-40. doi: 10.1136/hrt.2010.215350. Epub 2011 Apr 8.
9
Omega-3 fatty acids and atrial fibrillation.ω-3 脂肪酸与心房颤动。
Korean J Intern Med. 2023 May;38(3):282-289. doi: 10.3904/kjim.2022.266. Epub 2022 Dec 14.
10
n-3 Polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials.n-3 多不饱和脂肪酸预防术后心房颤动：随机对照试验的荟萃分析。
J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):104-9. doi: 10.2459/JCM.0b013e32834a13c1.
引用本文的文献
1
[Nutritional therapy in ophthalmology-patients' interest and motivation].[眼科营养治疗——患者的兴趣与动机]
Ophthalmologie. 2025 Jun 4. doi: 10.1007/s00347-025-02251-5.
2
Inflammation pathways as therapeutic targets in angiotensin II induced atrial fibrillation.炎症通路作为血管紧张素II诱导的心房颤动的治疗靶点
Front Pharmacol. 2025 Mar 3;16:1515864. doi: 10.3389/fphar.2025.1515864. eCollection 2025.
3
A Bayesian analysis of the VITAL trial: effects of ω-3 fatty acid supplementation on cardiovascular events.VITAL试验的贝叶斯分析：ω-3脂肪酸补充剂对心血管事件的影响。
Am J Clin Nutr. 2025 May;121(5):1046-1053. doi: 10.1016/j.ajcnut.2025.02.028. Epub 2025 Mar 1.
4
Dietary Interventions in Heart Failure With Preserved Ejection Fraction: A Scoping Review.射血分数保留的心力衰竭的饮食干预：一项范围综述
JACC Adv. 2024 Dec 17;4(1):101465. doi: 10.1016/j.jacadv.2024.101465. eCollection 2025 Jan.
5
Evaluating the Real-World Safety of Icosapent Ethyl Versus Omega-3 Polyunsaturated Fatty Acid in Nationwide US Veterans Cohort: Examining Atrial Fibrillation and Bleeding Endpoints.评估美国退伍军人全国队列中二十碳五烯酸乙酯与ω-3多不饱和脂肪酸的真实世界安全性：研究房颤和出血终点
Clin Drug Investig. 2025 Feb;45(2):69-84. doi: 10.1007/s40261-024-01417-4. Epub 2025 Jan 11.
6
Regulatory Compliance of Health Claims on Omega-3 Fatty Acid Food Supplements.ω-3脂肪酸食品补充剂健康声明的法规合规性。
Foods. 2024 Dec 29;14(1):67. doi: 10.3390/foods14010067.
7
Omega-3 Fatty Acids and Muscle Strength-Current State of Knowledge and Future Perspectives.Omega-3脂肪酸与肌肉力量——当前的知识现状与未来展望
Nutrients. 2024 Nov 27;16(23):4075. doi: 10.3390/nu16234075.
8
Omega-3 Supplementation in Coronary Artery Bypass Graft Patients: Impact on ICU Stay and Hospital Stay-A Systematic Review and Meta-Analysis.ω-3 脂肪酸补充剂对冠状动脉旁路移植术患者 ICU 入住时间和住院时间的影响：系统评价和荟萃分析。
Nutrients. 2024 Sep 29;16(19):3298. doi: 10.3390/nu16193298.
9
Inverse relationship between LDL-C/HDL-C ratio and atrial fibrillation in chronic kidney disease patients.LDL-C/HDL-C 比值与慢性肾脏病患者心房颤动呈负相关。
Sci Rep. 2024 Jul 31;14(1):17721. doi: 10.1038/s41598-024-67100-y.
10
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues.全身衰老引发心力衰竭：分子机制与治疗途径
ESC Heart Fail. 2025 Apr;12(2):1059-1080. doi: 10.1002/ehf2.14947. Epub 2024 Jul 22.
本文引用的文献
1
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.n-3脂肪酸补充剂对老年心肌梗死患者的影响：一项随机对照试验。
Circulation. 2021 Feb 9;143(6):528-539. doi: 10.1161/CIRCULATIONAHA.120.052209. Epub 2020 Nov 15.
2
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.高剂量ω-3 脂肪酸与玉米油对高心血管风险患者主要不良心血管事件的影响： STRENGTH 随机临床试验。
JAMA. 2020 Dec 8;324(22):2268-2280. doi: 10.1001/jama.2020.22258.
3
Impact of Different Doses of Omega-3 Fatty Acids on Cardiovascular Outcomes: a Pairwise and Network Meta-analysis.不同剂量 ω-3 脂肪酸对心血管结局的影响：一项成对和网络荟萃分析。
Curr Atheroscler Rep. 2020 Jul 16;22(9):45. doi: 10.1007/s11883-020-00865-5.
4
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.依泽替米贝降低严重高甘油三酯血症患者心血管风险
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
5
Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning.2000 年至 2010 年期间美国心房颤动住院治疗的当代趋势：对医疗保健规划的启示。
Circulation. 2014 Jun 10;129(23):2371-9. doi: 10.1161/CIRCULATIONAHA.114.008201. Epub 2014 May 19.
6
n-3 fatty acids in patients with multiple cardiovascular risk factors.多心血管危险因素患者的 n-3 脂肪酸。
N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409.
7
n-3 fatty acids and cardiovascular events after myocardial infarction.n-3 脂肪酸与心肌梗死后的心血管事件。
N Engl J Med. 2010 Nov 18;363(21):2015-26. doi: 10.1056/NEJMoa1003603. Epub 2010 Aug 28.
8
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.心肌梗死后补充 n-3 多不饱和脂肪酸和维生素 E：GISSI-Prevenzione 试验结果。意大利心肌梗死存活研究组
Lancet. 1999 Aug 7;354(9177):447-55.
Zotero 插件